Showing results (1191-1200 of 1,291) with videos related to

Sort By:
Pageof 130
Leukemia Research|January 16, 2021
Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre studyTamir Shragai, Moshe E Gatt, Adir Shaulov, et al.
British Journal of Haematology|July 1, 2021
Humoral response rate and predictors of response to BNT162b2 mRNA COVID19 vaccine in patients with multiple myelomaIrit Avivi, Roi Balaban, Tamir Shragai, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 7, 2024
Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 StudyAlbert Oriol, Roman Hájek, Ivan Spicka, et al.
Journal of Lipid Research|April 18, 2017
ANGPTL8 requires ANGPTL3 to inhibit lipoprotein lipase and plasma triglyceride clearanceJorge F Haller, Ivory J Mintah, Lisa M Shihanian, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 22, 2021
Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single-centre experienceOliver C Cohen, Michele Bertelli, Gavin Manmathan, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 3, 2026
Bispecific Antibodies Are Associated With Progressive Multifocal LeukoencephalopathyAvi Gadoth, Yael Paran, Yair Mina, et al.
ESC Heart Failure|September 14, 2020
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stageSteven Law, Aviva Petrie, Liza Chacko, et al.
Bone Marrow Transplantation|May 4, 2010
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registriesY C Cohen, A Scaradavou, C E Stevens, et al.
Atmospheric Measurement Techniques|July 17, 2020
Assessment of NO2 observations during DISCOVER-AQ and KORUS-AQ field campaignsSungyeon Choi, Lok N Lamsal, Melanie Follette-Cook, et al.
Neuro-Oncology|December 18, 2019
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE)Timothy F Cloughesy, Andrew Brenner, John F de Groot, et al.
Pageof 130